TASTE RESPONSES AND PREFERENCES FOR SWEET HIGH-FAT FOODS - EVIDENCE FOR OPIOID INVOLVEMENT

被引:219
作者
DREWNOWSKI, A [1 ]
KRAHN, DD [1 ]
DEMITRACK, MA [1 ]
NAIRN, K [1 ]
GOSNELL, BA [1 ]
机构
[1] UNIV MICHIGAN, SCH MED, DEPT PSYCHIAT, ANN ARBOR, MI 48104 USA
关键词
ENDOGENOUS OPIOID PEPTIDES; NALOXONE; BUTORPHANOL; OBESITY; BINGE EATING; TASTE RESPONSE; FOOD CONSUMPTION; SUGAR; FAT;
D O I
10.1016/0031-9384(92)90155-U
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
Preferences and cravings for sweet high-fat foods observed among obese and bulimic patients may involve the endogenous opioid peptide system. The opioid antagonist naloxone, opioid agonist butorphanol, and saline placebo were administered by intravenous infusion to 14 female binge eaters and 12 normal-weight controls. Eight of the binge eaters were obese. During infusion, the subjects tasted 20 sugar/fat mixtures and were allowed to select and consume snack foods of varying sugar and fat content. Naloxone reduced taste preferences relative to baseline in both binge eaters and controls. Total caloric intake from snacks was significantly reduced by naloxone in binge eaters but not in controls. This reduction was most pronounced for sweet high-fat foods such as cookies or chocolate. No consistent effects on taste preferences or food intakes were observed with butorphanol. Endogenous opioid peptides may be involved in mediating taste responses and preferences for palatable foods, notably those rich in sugar and fat.
引用
收藏
页码:371 / 379
页数:9
相关论文
共 76 条
[1]  
ABRAHAM S, 1983, DHHS831680 PUBL
[2]   NALTREXONE SUPPRESSES HYPERPHAGIA INDUCED IN THE RAT BY A HIGHLY PALATABLE DIET [J].
APFELBAUM, M ;
MANDENOFF, A .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1981, 15 (01) :89-91
[3]   SUPPRESSION OF NOCTURNAL, PALATABLE AND GLUCOPRIVIC INTAKE IN RATS BY THE KAPPA-OPIOID ANTAGONIST, NOR-BINALTORPHAMINE [J].
ARJUNE, D ;
BODNAR, RJ .
BRAIN RESEARCH, 1990, 534 (1-2) :313-316
[4]   REDUCTION BY CENTRAL BETA-FUNALTREXAMINE OF FOOD-INTAKE IN RATS UNDER FREELY-FEEDING, DEPRIVATION AND GLUCOPRIVIC CONDITIONS [J].
ARJUNE, D ;
STANDIFER, KM ;
PASTERNAK, GW ;
BODNAR, RJ .
BRAIN RESEARCH, 1990, 535 (01) :101-109
[5]   NALOXONE DECREASES FOOD-INTAKE IN OBESE HUMANS [J].
ATKINSON, RL .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1982, 55 (01) :196-198
[6]   EFFECTS OF LONG-TERM THERAPY WITH NALTREXONE ON BODY-WEIGHT IN OBESITY [J].
ATKINSON, RL ;
BERKE, LK ;
DRAKE, CR ;
BIBBS, ML ;
WILLIAMS, FL ;
KAISER, DL .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1985, 38 (04) :419-422
[7]  
BERTIERE MC, 1984, PHARMACOL BIOCHEM BE, V20, P675, DOI 10.1016/0091-3057(84)90183-7
[8]   INTERACTIONS BETWEEN SUCROSE, PAIN AND ISOLATION DISTRESS [J].
BLASS, E ;
FITZGERALD, E ;
KEHOE, P .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1987, 26 (03) :483-489
[9]  
Blass E. M., 1987, Sweetness, P115
[10]   SUPPRESSION OF DEPRIVATION-INDUCED FOOD AND WATER-INTAKE IN RATS AND MICE BY NALOXONE [J].
BROWN, DR ;
HOLTZMAN, SG .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1979, 11 (05) :567-573